Financial Performance - For the six months ended June 30, 2024, the group achieved a consolidated revenue of RMB 211,568,049, representing a year-on-year growth of 16.24% compared to RMB 185,915,928 for the same period in 2023[3]. - The consolidated gross profit for the same period was RMB 12,115,570, reflecting a significant year-on-year increase of 76.90% from RMB 6,848,825 in 2023[3]. - The loss attributable to equity holders of the company was RMB 4,123,183, an improvement from a loss of RMB 11,250,040 in the previous year, with basic loss per share decreasing to RMB 0.218 from RMB 0.594[3][5]. - Revenue for the six months ended June 30, 2024, was RMB 211,568,049, an increase from RMB 185,915,928 in the same period of 2023, representing a growth of approximately 13.8%[10]. - Fertilizer product sales amounted to RMB 211,314,827 for the six months ended June 30, 2024, compared to RMB 181,559,688 in 2023, indicating a year-on-year increase of about 16.4%[10]. - The company reported a basic loss per share of RMB (4,123,183) for the six months ended June 30, 2024, compared to RMB (11,250,040) in the same period of 2023, showing an improvement in loss[14]. Assets and Liabilities - Non-current assets totaled RMB 109,650,049 as of June 30, 2024, down from RMB 112,936,039 as of December 31, 2023[6]. - Current assets increased to RMB 200,402,798 from RMB 190,341,927, with cash and bank balances rising significantly to RMB 18,199,595 from RMB 5,934,322[6][8]. - Current liabilities amounted to RMB 224,172,039, compared to RMB 216,842,145 at the end of 2023, resulting in a negative net current asset position of RMB 23,769,241[7]. - The total assets of the company were valued at RMB 310,052,847, an increase from RMB 303,277,966[7]. - Total liabilities, including other payables and accrued expenses, rose to RMB 51,997,572 as of June 30, 2024, compared to RMB 47,464,251 as of December 31, 2023[19]. - As of June 30, 2024, the company's total assets were approximately RMB 310,052,847, with total liabilities of RMB 224,172,039, resulting in a debt-to-asset ratio of 0.81[32]. Cash Flow and Financing - Cash flows from operating activities showed a net cash inflow of RMB 8,044,015, compared to RMB 1,915,186 in the previous year[8]. - The company raised RMB 15,000,000 through short-term/long-term bank borrowings during the period[8]. - Financing expenses increased to RMB 1,977,660 for the six months ended June 30, 2024, up from RMB 1,521,452 in the same period of 2023, reflecting a rise of approximately 30%[10]. - Financing costs rose by 29.99% to RMB 1,977,660, compared to RMB 1,521,452 in the same period last year[30]. Expenses - Sales and distribution costs increased by 33.65% to RMB 7,053,114, driven by higher marketing expenses and sales team commissions due to increased revenue scale[28]. - Research and administrative expenses decreased by 37.85% to RMB 8,559,614, down from RMB 13,773,232 in the previous year[29]. Corporate Governance - The board of directors did not recommend the payment of any dividend for the six months ended June 30, 2024[3]. - The company maintained a registered capital of RMB 189,450,000 as of June 30, 2024, consistent with the previous year[20]. - The effective corporate income tax rate remained at 25% for the group, with certain subsidiaries benefiting from reduced rates[11]. - The audit committee, consisting of three independent non-executive directors, has reviewed the interim results for the six months ending June 30, 2024[43]. - The board of directors believes that the company has complied with all provisions of the Corporate Governance Code except for the separation of roles between the chairman and the CEO[48]. - No interim dividend was declared for the six months ending June 30, 2024[49]. Market and Business Development - The company is actively developing elderly health resource allocation services and has expanded its rental services for assistive devices in multiple locations[26]. - The company has strengthened its market sales management and adjusted product structure in response to market demand, ensuring steady progress in its compound fertilizer business[25]. - The fertilizer industry is experiencing structural reforms, leading to improved supply-demand balance and increased industry concentration[36]. - The company plans to enhance marketing management and adjust product structure based on market demand to increase market share in the compound fertilizer sector[36]. - The company is focusing on the elderly care industry, providing management consulting services and collaborating with international institutions to enhance its professional capabilities[36]. - The company has developed auxiliary equipment rental and elderly food sales businesses, with plans to expand into more categories of elderly products[36]. Shareholder Information - Major shareholders include Tianjin Economic-Technological Development Area State-owned Assets Management Company with 9.63% and Xiangyong Investment with 9.50% of the shares[40]. - As of June 30, 2024, the company’s directors and supervisors do not have any competitive interests with the group’s business[42]. - No new share option plans were approved during the first half of 2024[44]. - The company has not entered into any management contracts for its overall or major business operations during the first half of 2024[45]. - The company did not repurchase any shares during the review period[47].
泰达生物(08189) - 2024 - 中期业绩